|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,481.00 DKK | -0.20% |
|
+2.46% | -0.77% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology | 10.11B | 8.48B | 14.6B | 16.47B | 21.53B | |||||
Total Assets | 21.14B | 24.63B | 30.28B | 35.29B | 45.81B | |||||
Interest Expense | -10M | -13M | -21M | -27M | -120M | |||||
Income Tax Expense | 1.15B | 975M | 1.51B | 1.28B | 1.32B | |||||
CAPEX | -307M | -252M | -317M | -366M | -187M | |||||
EBT | 5.9B | 3.98B | 7.04B | 5.64B | 9.16B | |||||
D&A | 266M | 304M | 398M | 240M | 413M | |||||
Operating Income | 6.31B | 3.02B | 6.36B | 5.32B | 6.7B | |||||
Net Income | 4.76B | 3.01B | 5.52B | 4.35B | 7.84B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Denmark | 10.11B | 8.48B | 14.6B | 16.05B | 19.78B | |||||
Total Assets | 344M | 269M | 211M | 496M | 12.71B | |||||
United States of America | - | - | - | 380M | 902M | |||||
Total Assets | 370M | 470M | 442M | 378M | 3.2B | |||||
Total Assets | 380M | 422M | 793M | 874M | 767M | |||||
Japan | - | - | - | 41M | 841M | |||||
Total Assets | - | 95M | 70M | 56M | 100M | |||||
Total Assets | - | - | - | - | 48M |
- Stock Market
- Equities
- GMAB Stock
- Financials Genmab A/S
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition